tiprankstipranks
Milestone Pharmaceuticals reports Q3 EPS (14c) vs. (35c) last year
PremiumThe FlyMilestone Pharmaceuticals reports Q3 EPS (14c) vs. (35c) last year
2M ago
MIST Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
MIST Earnings this Week: How Will it Perform?
2M ago
Milestone partner announces Phase 3 study of etripamil met primary endpoint
Premium
The Fly
Milestone partner announces Phase 3 study of etripamil met primary endpoint
5M ago
Milestone Pharmaceuticals Eyes 2025 for CARDAMYST Launch
PremiumCompany AnnouncementsMilestone Pharmaceuticals Eyes 2025 for CARDAMYST Launch
5M ago
Milestone Pharmaceuticals reports Q2 EPS (14c), consensus (19c)
Premium
The Fly
Milestone Pharmaceuticals reports Q2 EPS (14c), consensus (19c)
5M ago
Milestone Pharmaceuticals Bolsters Board with New Directors
Premium
Company Announcements
Milestone Pharmaceuticals Bolsters Board with New Directors
6M ago
Milestone Pharmaceuticals reports Q1 EPS (21c), consensus (26c)
PremiumThe FlyMilestone Pharmaceuticals reports Q1 EPS (21c), consensus (26c)
8M ago
Is MIST a Buy, Before Earnings?
Premium
Pre-Earnings
Is MIST a Buy, Before Earnings?
8M ago
Milestone’s Etripamil Shows Promise in Self-Managed PSVT Treatment
Premium
Company Announcements
Milestone’s Etripamil Shows Promise in Self-Managed PSVT Treatment
9M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100